DOSIsoft, leading provider of patient-specific imaging and dosimetry software solutions for radiation oncology and nuclear medicine, is pleased to share that it has obtained 510(k) clearance from the US Food and Drug Administration (FDA) on June 12th, 2026, for the commercialization of ThinkQA 3.0.
As radiation therapy advances toward modern, time-constrained online Adaptive Radiation Therapy (ART), Patient Specific Quality Assurance (PSQA) processes must become faster, more reliable, and more integrated into clinical workflows. ThinkQA 3.0 addresses these challenges by combining speed, accuracy & simplicity into a unified web-based platform designed to support online ART workflow, for both CT-Linacs and MR-Linacs.
ThinkQA 3.0: Clinically Proven Design Innovation to Streamline Patient QA Experience
Ad Statistics
Times Displayed: 13401
Times Visited: 34 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
Automated PSQA: GPU-powered 3D Collapsed Cone Convolution (CCC) algorithm delivering QA results in just 1-2 minutes
Integrated workflow: seamless integration into Elekta ONE without adding time to the routine QA process
Centralized QA Management: all pre- & post- treatment PSQA tasks managed within a single and connected platform
Simplified QA user experience: Enhanced usability and modern web-based access to improve efficiency and ease of use
ThinkQA 3.0: Delivering End-to-End QA Capabilities for Adaptive Radiation Therapy
Tailored to meet the evolving requirements of adaptive radiotherapy, ThinkQA 3.0 represents a significant technological advancement, fully supporting both online and offline adaptive workflows. It is powered by a unique, fast, and optimized Collapsed Cone Convolution (CCC) calculation engine validated against Monte Carlo simulations. By leveraging the same calculation engine across all patient-specific QA verifications, ThinkQA 3.0 delivers consistent 3D dose calculations and 2D dose image comparisons while minimizing uncertainties and biases associated with multiple calculation engines.
Secondary dose check: Independent full 3D dose calculation, automatically handling adapt-to-position and adapt-to-shape plans
Logfile analysis: Automated pre-treatment and in vivo treatment verifications, based on machine delivery logs, and computed into 3D dose distributions.
Pretreatment check: EPID-based phantom-less QA providing instant gamma-based comparison results.
In vivo dosimetry check: EPID-based transit dosimetry QA for dose deviation detection during patient treatment.
ThinkQA 3.0: Designed for Broad Compatiblity and Seamless Implementation
